AzTrials
AzTrials

Dynamic Lung ComplianceNCT07161466

Effects of Positive End-Expiratory Pressure Levels on Lung Recruitment Duration and Hemodynamics After Alveolar Recruitment Maneuver: A Randomized Clinical Trial

A study testing lung recruitment maneuvre; PEEP in people with Dynamic Lung Compliance and Alveolar Recruitment Maneuver, run by Northern Jiangsu People's Hospital at 1 site in China.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

During general anesthesia surgery, the role of positive end-expiratory pressure (PEEP) in mechanical ventilation remains uncertain. Pressure levels above 0 cm H₂O can prevent postoperative pulmonary complications but may also cause intraoperative circulatory depression and lung injury due to overdistension. Read more about this study

Who is it for?
Ages 18 to 80 years
What is being tested?
lung recruitment maneuvre; PEEP
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
101 participants
Where
1 siteChina
Study dates
30 Aug 2025to 30 Nov 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • ASA physical status classification: Ⅰ or Ⅱ or Ⅲ
  • Adults aged 18 to 80 years, regardless of gender.
  • Patients undergoing elective laparoscopic colorectal cancer surgery under general anesthesia.
  • Patients who have provided written informed consent after understanding the study purpose, procedures, and potential risks.

Who cannot join

  • Recent thoracic surgery; radiographic evidence of pneumothorax, emphysema, or pulmonary bullae;
  • Pulmonary diseases: asthma or severe obstructive ventilatory dysfunction; preoperative pulse oxygen saturation (SpO2) < 90% on room air or < 95% with supplemental oxygen; contraindications to ARMs (e.g., intracranial hypertension, hypovolemic shock, or right heart failure);
  • severe cardiac disease (NYHA class III/IV, acute coronary syndrome, sustained ventricular tachycardia); concurrent participation in another trial; or refusal to provide informed consent

Trial locations and contacts

1 site in 1 country.

China1 site
  • Northern Jiangsu People's Hospital

    Yangzhou, Jiangsu

Other trials in China

About this study

During general anesthesia surgery, the role of positive end-expiratory pressure (PEEP) in mechanical ventilation remains uncertain. Pressure levels above 0 cm H₂O can prevent postoperative pulmonary complications but may also cause intraoperative circulatory depression and lung injury due to overdistension. Using very low levels of PEEP may lead to atelectasis. However, high levels of PEEP can not only trigger complications such as intraoperative circulatory depression but also promote hyperinflation. Positive end-expiratory pressure (PEEP) is required to prevent atelectasis during lung-protective ventilation, and different levels of PEEP exhibit varying physiological and clinical effects when used alone or in combination with alveolar recruitment maneuvers (ARM). Alveolar recruitment maneuvers (ARM) are used to open atelectatic lung parenchyma, but the duration of their benefits has not been clearly determined. This study aims to determine the effectiveness of different PEEP levels after ARM in general anesthesia surgery, the duration of their time-dependent responses, and their hemodynamic effects, providing a reference for how often recruitment maneuvers should be performed during general anesthesia and further refining the specific details of lung-protective ventilation strategies.

Being tested
lung recruitment maneuvre; PEEP

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • lung recruitment maneuvre; PEEPBehavioural

    After the patient enters the operating room, routine monitoring of ECG, non-invasive blood pressure, and SpO₂ is performed. Local anesthesia is used for radial artery puncture and catheterization to monitor invasive blood pressure.

    After 3 minutes of pre-oxygenation, tracheal intubation is performed with the following ventilation parameters: VT 6-8 ml/kg, FiO₂ 60%, RR 15 breaths/min, I/E 1:2, and PEEP 4 cmH₂O. Ten minutes after the establishment of pneumoperitoneum during surgery, baseline levels of respiratory mechanical parameters and hemodynamic variables are recorded. Subsequently, alveolar recruitment is performed at a pressure of 30 cmH₂O for 30 seconds. Immediately after recruitment, the PEEP level is adjusted according to the group. The changes in respiratory mechanics parameters and hemodynamic variables after recruitment are recorded. After the outcome indicators recover to the new baseline level, the PEEP is readjusted to 4 cmH₂O.

Study groups in NCT07161466
Study groupRoleWhat they receive
A: PEEP=0 cmH2OPlacebo comparatorBaseline respiratory mechanics parameters (driving pressure [DP], dynamic lung compliance [Cdyn]) and hemodynamic parameters (mean arterial pressure [MAP], SV, CO, CI) were recorded before ARM. Ten minutes after insufflation of the peritoneum with CO2 and positioning of the patient for surgery, an ARM was performed using the built-in protocol of the Mindray anesthesia machine, applying a continuous positive pressure of 30 cmH2O for 30 seconds. Immediately afterwards, the PEEP level was adjusted to 0 cmH2O. Respiratory and hemodynamic parameters were recorded at 5, 10, 15, 20, 25, 30, 35, and 40 minutes after ARM. The PEEP level was set back to 4 cmH2O forty minutes after ARM until the end of surgery.
Receives: Behavioral: lung recruitment maneuvre; PEEP
B: PEEP=4cmH2OExperimentalBaseline respiratory mechanics parameters (driving pressure [DP], dynamic lung compliance [Cdyn]) and hemodynamic parameters (mean arterial pressure [MAP], SV, CO, CI) were recorded before ARM. Ten minutes after insufflation of the peritoneum with CO2 and positioning of the patient for surgery, an ARM was performed using the built-in protocol of the Mindray anesthesia machine, applying a continuous positive pressure of 30 cmH2O for 30 seconds. Immediately afterwards, the PEEP level was adjusted to 4 cmH2O. Respiratory and hemodynamic parameters were recorded at 5, 10, 15, 20, 25, 30, 35, and 40 minutes after ARM. The PEEP level was set back to 4 cmH2O forty minutes after ARM until the end of surgery.
Receives: Behavioral: lung recruitment maneuvre; PEEP
C: PEEP=8cmH2OExperimentalBaseline respiratory mechanics parameters (driving pressure [DP], dynamic lung compliance [Cdyn]) and hemodynamic parameters (mean arterial pressure [MAP], SV, CO, CI) were recorded before ARM. Ten minutes after insufflation of the peritoneum with CO2 and positioning of the patient for surgery, an ARM was performed using the built-in protocol of the Mindray anesthesia machine, applying a continuous positive pressure of 30 cmH2O for 30 seconds. Immediately afterwards, the PEEP level was adjusted to 8 cmH2O. Respiratory and hemodynamic parameters were recorded at 5, 10, 15, 20, 25, 30, 35, and 40 minutes after ARM. The PEEP level was set back to 4 cmH2O forty minutes after ARM until the end of surgery.
Receives: Behavioral: lung recruitment maneuvre; PEEP
D: PEEP=12cmH2OExperimentalBaseline respiratory mechanics parameters (driving pressure [DP], dynamic lung compliance [Cdyn]) and hemodynamic parameters (mean arterial pressure [MAP], SV, CO, CI) were recorded before ARM. Ten minutes after insufflation of the peritoneum with CO2 and positioning of the patient for surgery, an ARM was performed using the built-in protocol of the Mindray anesthesia machine, applying a continuous positive pressure of 30 cmH2O for 30 seconds. Immediately afterwards, the PEEP level was adjusted to 12 cmH2O. Respiratory and hemodynamic parameters were recorded at 5, 10, 15, 20, 25, 30, 35, and 40 minutes after ARM. The PEEP level was set back to 4 cmH2O forty minutes after ARM until the end of surgery.
Receives: Behavioral: lung recruitment maneuvre; PEEP

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. the duration of improvement in lung compliance

    Measured: during the surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Sep 2025
  2. Study start30 Aug 2025
  3. Primary completion30 Nov 2025
  4. Study completion30 Nov 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Investigator
Enrolment
101 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07161466
Sponsor's protocol ID
2024ky380
Status last verified
Aug 2025
First submitted
30 Aug 2025
Last updated
24 Mar 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing lung recruitment maneuvre; PEEP in people with Dynamic Lung Compliance and Alveolar Recruitment Maneuver, run by Northern Jiangsu People's Hospital at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 24 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

the duration of improvement in lung compliance (time frame: during the surgery). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Mar 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in